baber/WOPTO huggingface dataset:
Patent CA-2670369-A1 (CA)
Inventor: HAMM DONALD JOSEPH
IPC: A23L29/10
Filed: 2007-12-04
Abstract: The present invention relates to an edible water-continuous oil-and-water emulsion having a pH in the range of 2.0-5.0, said emulsion comprising: 5-90 wt.% of an oil phase; 10-95 wt.% of an aqueous phase; 0.3-30% by weight of the aqueous phase of one or more egg yolk granule proteins selected from high density lipoprotein (HDL) and phosvitin; and from 0.05% up to 10 wt.% of the aqueous phase of one or more egg yolk plasma proteins selected from low density lipoprotein (LDL) and livetin; wherein the weight ratio of the egg yolk granule proteins to the egg yolk plasma proteins exceeds 1:1. It was discovered that egg yolk granule proteins can advantageously be used to stabilise acidic water-continuous oil-and-water emulsions such as mayonnaise and dressings.
Patent CA-2671610-A1 (CA)
Title: Enhanced wireless usb protocol and hub
Inventor: CHRISTISON GREGORY L
IPC: G06F13/36
Filed: 2007-12-21
Abstract: The present invention provides a method for improving data throughput for a wireless USB system that includes wire adapters that wirelessly transmit data between a host system and a wired USB device. The invention also provides a Wireless USB hub that acts as a proxy for the wired USB devices and presents them to a host either as unique WUSB devices with their own addresses or as separate functions on an already existing WUSB device.
Patent CA-2673921-A1 (CA)
Inventor: LOEHN MATTHIAS
IPC: C07D401/12
Filed: 2007-12-19
Abstract: The invention relates to 6-substituted isoquinoline and isochinolone derivatives of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
Patent CA-2678600-A1 (CA)
Title: Integrated dental abutment block
Inventor: MORGAN VINCENT J
IPC: A61C8/00
Filed: 2008-02-22
Abstract: An integrated abutment block has an abutment with an internal portion imbedded in the block and a depending post.
Patent CA-2678611-A1 (CA)
Inventor: MEYER MIKE
IPC: A61L31/16
Filed: 2007-12-11
Abstract: The invention relates to a medical device, such as an intravascular stent, useful for delivering two or more therapeutic agents to a body tissue of a patient at different rates, and methods for making and using such medical device. The medical device includes a substrate and/or coating having a plurality of pores, dispersed in said pores are a plurality of a first and a second therapeutic agents, wherein said first therapeutic agent is bonded to one or more molecule(s) of a first material and the second therapeutic agent bonded to one or more molecule(s) of a second material, such that when the medical device, is in use (e.g., implanted into a body lumen such as a blood vessel), bonded first therapeutic agent is released from the medical device at a rate that is slower than the rate at which the bonded second therapeutic agent is released from the medical device.
Patent CA-2681661-A1 (CA)
Inventor: GUTIERREZ RODRIGO A
IPC: A23L7/10
Filed: 2008-03-24
Abstract: Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding CCAl, GLKl or bZIPl, operably linked to a plant-specific promote, wherein the CCAl, GLKl or bZIPl is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In other embodiments, transgenic plants in which express a lower level of CCA 1, GLKl or bZIPl are provided. Also provided herein are commercial products {e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein.
Patent CA-2682497-A1 (CA)
Inventor: MUCKE LENNART
IPC: G01N33/00
Filed: 2008-04-04
Abstract: The present invention provides methods of identifying candidate agents fo r treating excitotoxicity-related disorders. The present invention further p rovides methods for treating excitotoxicity-related disorders.
Patent CA-2682515-A1 (CA)
Title: Low foaming aqueous sterilizing compositions
Inventor: WHITELEY GREGORY STUART
IPC: A61L2/18
Filed: 2008-03-28
Abstract: Disclosed is a sterilizing composition including (i) at least one mono or dialdehyde; (ii) at ieast one glycol or polyol or derivative thereof; (iii) a non-ionic first surfactant; and (iv) a second surfactant having a cloud p oint in the range of about 30~C to 50~C. Also disclosed is a sterilizing com position including (i) at least one mono or dialdehyde;(ii) at least one gly col or polyol or derivative thereof; (iii) a non-ionic first surfactant; and (iv) a second surfactant, wherein the second surfactant is a quaternary amm onium compound, A process for preparing the compositions of the invention is also disclosed. The compositions of the invention are low or substantially non-foaming under high pressure, high temperature conditions, thus allowing maximum benefit from the new, more reliable, generation of automated endosco pe reprocessing machine
Patent CA-2682854-A1 (CA)
Inventor: SOETERMANS MAXIMILIANO
IPC: A61B1/018
Filed: 2008-04-02
Abstract: An endoscope apparatus for endoscopic treatment is disclosed. The apparatus comprises an endoscopic insertion tube comprising an outer surface including an outer rail formed longitudinally thereon and extending along a portion of the insertion tube. The outer rail has a predetermined shape. The insertion tube comprises an inner channel formed therethrough. An endoscope apparatus for endoscopic treatment is disclosed. The apparatus comprises an endoscopic insertion tube without a working channel and an outer surface including at least one outer rail formed longitudinally thereon and extending along a portion of the insertion tube. The outer rail has a first predetermined shape. At least one medical device includes an outer wall having at least one mounting unit formed thereon along a portion of the length of the outer wall. The mounting unit has a second predetermined shape cooperable with the first predetermined shape. The second predetermined shape is formed to complement and slidably cooperate with the first predetermined shape of the outer rail for slidably attaching the medical device thereto.
Patent CA-2684359-A1 (CA)
Title: Procede de synthese de catalyseurs heterogenes au palladium, catalyseurs obtenus et utilisations de ces derniers
Inventor: LE DRIAN CLAUDE
IPC: B01J31/16
Filed: 2008-04-11
Abstract: La présente invention concerne le domaine de la chimie, en particulier de la chimie organique et plus particulièrement le domaine des catalyseurs hét érogènes au palladium qui sont utilisés pour catalyser des réactions chimiqu es impliquant la formation de liaisons carbone-carbone. Elle a pour objet un procédé de synthèse d'un catalyseur hétérogène au palladium susceptible de catalyser une réaction de couplage C-C, comprenant les étapes consistant ess entiellement à mettre à disposition un support solide sur lequel on a fixé d e façon covalente des groupements de formule -PR1R2, dans laquelle R1 représ ente un groupement alkyle, éventuellement substitué,ou cycloalkyle,éventuell ement substitué, et R2 représente un groupement aryle,éventuellement substit ué, ou un groupement hétéroaryle,éventuellement substitué,et à incorporer un e quantité catalytiquement efficace de palladium dans ledit support ainsi su bstitué. Elle a également pour objet les catalyseurs obtenus et les utilisat ions desdits catalyseurs dans des réactions de couplage C-C.
Patent CA-2685675-A1 (CA)
Inventor: JUNG SANG TAEK
IPC: C07K16/28
Filed: 2008-04-30
Abstract: Methods and composition for the screening and isolation of aglycosylated antibody Fc domain polypeptides. For example, in certain aspects methods for identifying aglycosylated Fc domains that bind to Fc receptors or preferentially bind to particular Fc receptors are described. Furthermore, the invention provides aglycosylated Fc domains that bind to Fc receptors with high affinity. Enhanced methods and media for prokaryotic based interaction screening are also provided.
Patent CA-2687927-A1 (CA)
Title: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
Inventor: MULLER GEORGE W
IPC: C07D401/04
Filed: 2004-09-03
Abstract: Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of making the polymorphic forms and methods of their use are also disclosed.
Patent CA-2688773-A1 (CA)
Inventor: YANG TAI-HER
IPC: F28D19/04
Filed: 2009-12-17
Abstract: The present invention discloses that a rotary type heat exchange apparatus with automatic flow rate exchange modulation is installed with the tree or at least one kind of at least one temperature detecting device, at least one humidity detecting device and at least one gaseous or liquid state fluid composition detecting device at the position capable of detecting the temperature, humidity, and composition changes of the exchange fluid, wherein the detected signals are used as the references for modulating the pumping flow rate of exchange fluid, or for modulating the operating timing such as the rotating speed of the rotary type heat exchange rotating disk.
Patent CA-2696157-A1 (CA)
Inventor: ENDERS GERDUM
IPC: F23B10/00
Filed: 2010-03-12
Abstract: A method is provided for regulating the output of a solid fuel furnace having primary and secondary combustion chambers arranged adjacent to each other, in particular one above the other or side by side, and are separated from each other by a partition in the floor or wall but are nevertheless connected to each other by at least one partition opening The secondary combustion chamber is connected through a secondary exhaust-gas channel to a flue-gas passage, and the primary combustion chamber is connected to the flue-gas passage by a transition opening, wherein the transition opening can be closed at least partially by a flue-gas flap Both a primary air supply and a secondary air supply are provided. A first temperature sensor is arranged in the secondary exhaust-gas channel and controls the primary air volume flow as a function of the temperature in the secondary exhaust-gas channel, while the secondary air volume flow is held substantially constant
Patent CA-2697549-A1 (CA)
Title: A water dispersible formulation for delivery of biocontrol fungi to reduce aflatoxin
Inventor: LYN MARGARET
IPC: A01N63/34
Filed: 2008-08-27
Abstract: A formulation containing conidia of non-toxigenic strains of fungi is a useful biocontrol agent for preventing toxin contamination in agricultural commodities, especially those for human and animal consumption such as peanuts, com, cotton and tree nuts. The formulation of the invention is a water dispersible granule formulation suitable for spraying and includes non-toxigenic and/or non-aflatoxigenic Aspergillus flavus strains capable of inhibiting growth of fungi which produce aflatoxin and further capable of suppressing production of aflatoxin by the toxigenic fungi. A method of preparing the formulation is shown.
Patent CA-2697888-A1 (CA)
Title: Device for predicting prognosis of patients who undergo peg operation, method for predicting prognosis of patients who undergo peg operation and computer readable medium
Inventor: HIBI TOSHIFUMI
IPC: G16H20/40
Filed: 2009-03-19
Abstract: The present invention provides a device for predicting prognosis of a patient who undergoes PEG, which allows a doctor to obtain predictive results sufficient to judge whether or not to perform the PEG (percutaneous endoscopic gastrostomy) for the patient. This device includes: a prognosis prediction expression storage section 14 that stores a prognosis prediction expression, the prognosis prediction expression being calculated by applying prediction input factors and prediction output factors about a first patient who already underwent the PEG, to ANN (artificial neural network); and a processing section 16 that inputs diagnosis input factors about a second patient, for judging whether or not to perform the PEG on the second patient, calculates diagnosis output factors in response to the diagnosis input factors by referring to the prognosis prediction expression stored in the prognosis prediction expression storage section and then outputs the calculated diagnosis output factors.
Patent CA-2698757-A1 (CA)
Inventor: YALE DAVID P
IPC: E21B43/26
Filed: 2008-08-26
Abstract: Methods for recovering heavy oil are provided. In at least one embodiment, the process includes conditioning a reservoir of interest, then initially producing fluids and particulate solids such as sand to increase reservoir access ("slurry produc-tion"). The initial production may generate high permeability channels or wormholes in the formation, which may be used for heavy oil production processes ("hydrocarbon production") such as cold flow (CHOPS) or enhanced production processes such as SAGD, or VAPEX.
Patent CA-2699340-A1 (CA)
Inventor: SONG BONGYONG
IPC: H04L47/32
Filed: 2008-09-19
Abstract: Aspects of managing acknowledgment transmis-sions from multicast group members of a multicast group within a wireless communications network are disclosed. An access net-work transmits an announce message announcing a multicast ses-sion to a plurality of access terminals. One of the plurality of ac-cess terminals (i.e., a first responder) sends a BCMCSFlowReg-istration message and an announce acknowledgment (ACK) mes-sage to the access network. In an example, the BCMCSFlowRegistration message and announce ACK message are sent within the same access probe on a reverse link access channel. Next, the ac-cess network sends, in response to the received BCMCSFlowReg-istration message, a suppression message to request access termi-nals not to send announce acknowledgment messages for the an-nounced multicast session. Alternatively, an application server sends the suppression message in response to the received an-nounce ACK message. In either scenario, the access terminals receiving the suppression message suppress transmission of sub-sequent announce ACK messages.
Patent CA-2700600-A1 (CA)
Title: Dispositif de chapeau et de filtre de conduit de cheminee pour un appareil chauffe au gaz
Inventor: ARNOLD JOHN G JR
IPC: F23J15/02
Filed: 2008-07-22
Abstract: L'invention porte sur un dispositif de chapeau et de filtre de conduit de cheminée (10) pour un appareil chauffé au gaz en communication avec une ouverture de conduit de cheminée ayant un tuyau externe (13) et une chemise coaxiale (14). Le dispositif comprend un chapeau tubulaire (16) avec une extrémité inférieure ouverte (18), une extrémité supérieure ouverte opposée (20), et une pluralité de trous de ventilation (22), le chapeau pouvant être reçu sur l'ouverture de conduit. Une partie supérieure amovible (24) est fixée à l'extrémité supérieure ouverte du chapeau tubulaire et ferme cette extrémité. Un plateau de filtre (40), ayant un diamètre plus petit que le chapeau tubulaire, comprend un rebord (44) s'étendant radialement vers l'intérieur depuis le plateau. Un insert de filtre de conversion catalytique amovible (50) à l'intérieur du chapeau tubulaire est supporté sur le rebord.
Patent CA-2704551-A1 (CA)
Inventor: KOLAS STEINAR
IPC: G05B13/04
Filed: 2008-11-12
Abstract: Method and means for controlling an electrolysis cell for aluminium production by process control inputs, comprising means for measurement of one or more process variable(-s) where the measured value(-s) is led to an estimator. The estimator can be of the Kalman filter type, and estimates the current value of one or more process variable(-s) followed by prediction of the value of said process variable(-s) and/or other process variable(-s). The predicted value(-s) is used to calculate future input control scenario by means of a calculator. The prediction of the process variable(-s) is performed in accordance with a non -linear dynamic model being an integrated part of a process controller.
Patent CA-2704887-A1 (CA)
Title: Volumetric metering system with sectional shut-off
Inventor: SNIPES TERRY LEE
IPC: A01C7/08
Filed: 2010-05-21
Abstract: A volumetric metering system for a seeding machine is provided with movable gates disposed downstream from the meter roller but before the product enters a distribution system to selectively stop the flow of product through sections of the metering system. By placing the shut-off gate after the meter but before product enters the distribution system, there will not be a delay in stoppage of product flow while the meter empties of product. Furthermore, by locating the gate before the distribution system, the metered product is not mixed with the air stream or with additional products, causing a need for product redirection into a pressurized tank or separation of multiple products.
Patent CA-2708359-A1 (CA)
Inventor: GHINELLI SERAFINO
IPC: B24D5/12
Filed: 2008-01-28
Abstract: The present invention relates to an abrasive tool, of the type suitable to be mounted on a machine tool, comprising at least a bearing structure with abrasive material, the said bearing structure being provided with at least a grid (6) with abrasive material, the grid (6) partially protruding or emerging from a body (7) without abrasive material.
Patent CA-2709147-A1 (CA)
Inventor: BONISLAWSKI DAVID J
IPC: C01B15/037
Filed: 2007-12-13
Abstract: The present invention is directed to a stabilized hydrogen peroxide solution containing stabilizers that maintain relatively high hydrogen peroxide stability in both concentrated form and when formulated into a cleaning solution that has a pH above 6 and contains components that normally would have a destabilizing effect on the hydrogen peroxide. The stabilizers include a first cyclic amino methane diphosphonic acid compound stabilizer in combination with a second phosphonic acid based stabilizer (different from the cyclic amino methane diphosphonic acid compound), wherein the weight ratio of the first stabilizer to the second stabilizer is at least about 2:1.
Patent CA-2712353-A1 (CA)
Inventor: CASH JAMES T
IPC: F27D99/00
Filed: 2003-03-25
Abstract: Valve (25) with heated sealing gas suitable for use in a regenerative thermal oxidizer (10), and oxidizer including the switching valve. The valve of the present invention exhibits excellent sealing characteristics and minimizes wear. In a preferred embodiment, the valve utilizes hot gas from the regenerative process to heat gas for scaling the valve, and scaling air flows through a heat exchanger (212) that is positioned to be in contact with hot exhaust gas from the regenerative process.
Patent CA-2713525-A1 (CA)
Inventor: EBEL JAMES PATRICK
IPC: A61K35/745
Filed: 2009-02-06
Abstract: Disclosed herein are compositions for treating a respiratory condition, preferably by enhancing immune response in a mammal, the compositions including a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an ad-ditional component. Also included are methods of treating a respiratory condition, preferably by enhancing immune response, in a mammal. Kits containing the compositions, and instructions for applying the methods are also included. The method includes orally administering to the mammal a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component.
Patent CA-2713690-A1 (CA)
Inventor: POBUDA DAVID W
IPC: F02N15/10
Filed: 2009-01-28
Abstract: A message-generating motor vehicle ignition key comprises a key portion for coupling with an ignition switch and a grip portion for grasping by an operator of the motor vehicle. The grip portion comprises a housing defining at least one chamber therein, a controller having a processor, memory, and associated operational components received in the at least one chamber, a battery received in the at least one chamber, electrically coupled with the controller, and supplying the controller with power to operate the controller, and a message generator received in the at least one chamber and electrically coupled with the controller to receive a signal from the controller. Data can be stored in the memory and processed by the processor into a signal delivered to the message generator to generate a spoken message.
Patent CA-2714088-A1 (CA)
Inventor: VERWAAL RENE
IPC: C12P7/46
Filed: 2009-02-13
Abstract: The present invention relates to a process for the production of a dicarboxylic acid wherein a eukaryotic cell is fermented in a suitable fermentation medium.    The invention further relates to a eukaryotic cell comprising a nucleotide sequence encoding an enzyme which catalyses the conversion of isocitric acid to succinic acid, and a nucleotide sequence encoding an enzyme which catalyses the conversion of glyoxylic acid to malic acid.
Patent CA-2714477-A1 (CA)
Title: Procedes et complexes renfermant des particules phagiques
Inventor: WINTER GREGORY
IPC: G01N33/68
Filed: 2009-02-04
Abstract: L'invention concerne un complexe incluant une particule phagique, ladite particule phagique incluant (i) un polypeptide; (ii) un acide nucléique codant le polypeptide de (i); et (iii) un composé connecteur fixé audit polypeptide par au moins 3 liaisons covalentes discrètes. L'invention concerne aussi des bibliothèques et des procédés de production de complexes et des procédés de criblage utilisant ces derniers.
Patent CA-2714985-A1 (CA)
Inventor: BRIGATTI LUCA
IPC: A61K51/00
Filed: 2009-01-07
Abstract: Methods and devices for minimally-invasive delivery of radiation to the posterior portion of the eye including a cannula comprising a distal portion connected to a proximal portion and a means for advancing a radionuclide brachytherapy source (RBS) toward the tip of the distal portion; a method of introducing radiation to the human eye comprising inserting a cannula between the Tenon's capsule and the sclera of the human eye and emitting the radiation from the cannula on an outer surface of said sclera.
Patent CA-2717034-A1 (CA)
Title: Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease
Inventor: FURET PASCAL
IPC: A61P35/00
Filed: 2009-02-26
Abstract: The invention relates to compounds of formula (I) and salts thereof, formula (I) wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharamaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
Patent CA-2717777-A1 (CA)
Inventor: WRIGHTMAN ROBERT A
IPC: B62B17/04
Filed: 2010-10-18
Abstract: A strut to connect a ski assembly to a snowmobile suspension comprising a spindle having at least one attachment point to secure the spindle to suspension components and having a first abutment face. A saddle assembly extending from the spindle for connection to the ski assembly and having a second abutment face oppositely directed to the first abutment face. A connector to hold the abutment faces in engagement to provide a unitary strut.